Unadjusted cumulative incidence of mortality and MI
| <6 METS | 6–9 METS | 10–11 METS | ≥12 METS | |
|---|---|---|---|---|
| Mortality | ||||
| <40 | 17% (12% to 23%) | 4% (3% to 6%) | 1% (1% to 2%) | 1% (1% to 1%) |
| 40–49.9 | 14% (12% to 17%) | 4% (4% to 5%) | 2% (2% to 3%) | 2% (1% to 2%) |
| 50–59.9 | 16% (14% to 18%) | 6% (5% to 7%) | 4% (4% to 5%) | 3% (2% to 4%) |
| 60–69.9 | 27% (25% to 29%) | 13% (12% to 14%) | 8% (7% to 9%) | 6% (5% to 9%) |
| ≥70 | 42% (40% to 44%) | 27% (25% to 29%) | 22% (19% to 25%) | 11% (6% to 23%) |
| MI | ||||
| <40 | 4% (2% to 8%) | 1% (1% to 2%) | 1% (1% to 1%) | 0% (0% to 1%) |
| 40–49.9 | 3% (2% to 5%) | 1% (1% to 2%) | 1% (1% to 1%) | 1% (0% to 1%) |
| 50–59.9 | 3% (2% to 4%) | 2% (2% to 3%) | 1% (1% to 1%) | 1% (1% to 1%) |
| 60–69.9 | 5% (4% to 6%) | 3% (2% to 3%) | 1% (1% to 2%) | 1% (1% to 2%) |
| ≥70 | 7% (6% to 9%) | 5% (4% to 6%) | 4% (3% to 6%) | 5% (2% to 16%) |
Unadjusted cumulative incidence of mortality and MI by age groups at median follow-up of 10.4 and 5.5 years, respectively, with stratification by METS categories. 95% CIs shown in parentheses. p Value shows the variance across METS categories within each age group.
METS, metabolic equivalents; MI, myocardial infarction.